). Transfection is an essential technique applied to many fields of science. Reproducible results in some specific cell lines are not easily achieved in standard transfection setups. The…
Ended Awarded Last action
- Contract number
- 75N91021F00178
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $18,000
Award facts
- Contract value 100% obligated
- $18,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $18,000 |
About this award
The National Cancer Institute awarded a $18,000 firm fixed price BPA call to Lonza Walkersville, Inc. on June 24, 2021, with an ultimate completion date of August 31, 2021. This contract was executed without set-aside designation, indicating open competition. The award supports the provision of transfection technology and related scientific equipment to be delivered at Lonza's Walkersville, Maryland facility. Transfection is a critical laboratory technique used to introduce genetic material into cells, and Lonza's Nucleofector technology provides reproducible results across diverse cell lines that are challenging to achieve with standard transfection methods.
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment, serves as a key supplier to the federal biomedical research community through its subsidiary operations in Maryland. This contract represents a call against Lonza's $10 million single-award Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The BPA facilitates streamlined procurement of specialized research equipment, biological materials, and scientific supplies across multiple NIH institutes and research centers, with individual task orders typically ranging from approximately $10,000 to $24,000, supporting critical research in cancer studies, infectious diseases, and cellular engineering.
Description
). Transfection is an essential technique applied to many fields of science. Reproducible results in some specific cell lines are not easily achieved in standard transfection setups. The nucleofector technology, along with its library of pre-written
Quick answers
Who was awarded contract 75N91021F00178?
75N91021F00178 was awarded to Lonza Walkersville, Inc. by National Cancer Institute (National Institutes of Health) on June 24, 2021.
How much is contract 75N91021F00178 worth?
The government has obligated $18,000 on 75N91021F00178.
Is contract 75N91021F00178 an order under another contract?
Yes. 75N91021F00178 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract 75N91021F00178 competed?
The extent of competition for 75N91021F00178 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award